PHARMASECURITY

Pharmaceuticals and Security: The Role of Public-Private Collaborations in Strengthening Global Health Security

 Coordinatore UNIVERSITY OF SUSSEX 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 1˙197˙693 €
 EC contributo 1˙197˙693 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2012-StG_20111124
 Funding Scheme ERC-SG
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-02-01   -   2018-01-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY OF SUSSEX

 Organization address address: Sussex House
city: FALMER, BRIGHTON
postcode: BN1 9RH

contact info
Titolo: Mr.
Nome: David
Cognome: Rose
Email: send email
Telefono: +44 1273 876592
Fax: +44 1273 678192

UK (FALMER, BRIGHTON) hostInstitution 1˙197˙693.80
2    UNIVERSITY OF SUSSEX

 Organization address address: Sussex House
city: FALMER, BRIGHTON
postcode: BN1 9RH

contact info
Titolo: Prof.
Nome: Stefan
Cognome: Elbe
Email: send email
Telefono: 441274000000

UK (FALMER, BRIGHTON) hostInstitution 1˙197˙693.80

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

industry    policy    threats    companies    crucial    transnational    health    security    play    pharmaceutical    public   

 Obiettivo del progetto (Objective)

'Governments in Europe (and beyond) have begun to express grave concern about a number of acute, transnational health threats endangering their citizens and economies. Whether it is the spectre of a future pandemic, the threat of a bioterrorist attack, or the continuing burden of infectious diseases in many developing countries - strengthening the protection against transnational public health threats is increasingly viewed as an urgent matter of international politics. Ongoing efforts by the European Union to develop its own health security strategy will require the formation of effective and sustainable partnerships with numerous stakeholders, including the scientific, medical, and public health communities, as well as private industry – especially in the form of pharmaceutical companies. The latter are particularly crucial actors because of the prominent role that pharmaceutical therapies like vaccines, antivirals, antibiotics, etc. play in strengthening health security. Cooperation with the pharmaceutical industry is therefore necessary to ensure that the required drugs are available in sufficient quantities, in the places where they are needed, and at the right time. Yet very little – if anything – is actually known about the role of pharmaceutical companies in the formulation and implementation of health security policy. This crucial area not only remains under-researcher; it is, in fact, almost entirely un-researched. The core research challenge this project takes up, therefore, is to conduct the first systematic study of the role of pharmaceutical businesses in health security. The aim of the project is both to improve our understanding of the role that pharmaceutical companies play in shaping contemporary health security policy, and to explore how the emerging (but also politically sensitive) partnerships with pharmaceutical companies can be responsibly managed in the years ahead.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

NEWHEAVYFERMION (2010)

Novel materials and extreme conditions to open new frontiers in heavy fermion physics

Read More  

GALE (2011)

Games and Automata for Logic Extensions

Read More  

CRASH (2011)

CRyptographic Algorithms and Secure Hardware

Read More